These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 1536067

  • 1. Recognizing and reporting adverse drug reactions.
    Lucas LM, Colley CA.
    West J Med; 1992 Feb; 156(2):172-5. PubMed ID: 1536067
    [Abstract] [Full Text] [Related]

  • 2. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK, Swartz L.
    Arch Intern Med; 2005 Jun 27; 165(12):1363-9. PubMed ID: 15983284
    [Abstract] [Full Text] [Related]

  • 3. Improving the reporting of adverse drug reactions in the hospital setting.
    Pushkin R, Frassetto L, Tsourounis C, Segal ES, Kim S.
    Postgrad Med; 2010 Nov 27; 122(6):154-64. PubMed ID: 21084792
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.
    Coté TR, Mohan AK, Polder JA, Walton MK, Braun MM.
    J Am Acad Dermatol; 2005 Sep 27; 53(3):407-15. PubMed ID: 16112345
    [Abstract] [Full Text] [Related]

  • 5. Toward improved adverse event/suspected adverse drug reaction reporting.
    Gross R, Strom BL.
    Pharmacoepidemiol Drug Saf; 2003 Mar 27; 12(2):89-91. PubMed ID: 12642971
    [No Abstract] [Full Text] [Related]

  • 6. National adverse drug reaction reporting. 1984-1989.
    Faich GA.
    Arch Intern Med; 1991 Aug 27; 151(8):1645-7. PubMed ID: 1872669
    [Abstract] [Full Text] [Related]

  • 7. An evaluation of spontaneous adverse drug reaction monitoring systems.
    Sachs RM, Bortnichak EA.
    Am J Med; 1986 Nov 28; 81(5B):49-55. PubMed ID: 3789003
    [Abstract] [Full Text] [Related]

  • 8. Food and Drug Administration monitoring of adverse drug reactions.
    Sills JM, Tanner LA, Milstien JB.
    Am J Hosp Pharm; 1986 Nov 28; 43(11):2764-70. PubMed ID: 3799612
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adverse drug reactions, MedWatch reporting and medical student education.
    Lewis LD, Nierenberg DW.
    Pharmacoepidemiol Drug Saf; 2003 Mar 28; 12(2):93-5. PubMed ID: 12642972
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Adverse drug effect notifications by nurses and comparison with cases reported by physicians].
    Sacilotto K, Bagheri H, Lapeyre-Mestre M, Montastruc JL, Montastruc P.
    Therapie; 1995 Mar 28; 50(5):455-8. PubMed ID: 8571285
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.
    Clark JA, Humphries JE, Crean S, Reynolds MW.
    Pharmacoepidemiol Drug Saf; 2010 Feb 28; 19(2):107-14. PubMed ID: 20014051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.